RECCAS - REmoval of Cytokines during CArdiac Surgery: Study protocol for a randomised controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Baumann, Andreas ^a   Buchwald, Dirk ^a   Annecke, Thorsten ^b   Hellmich, Martin ^b   Zahn, Peter K ^a   Hohn, Andreas ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Cytokines; Glycocalyx shedding; Haemoadsorption; Inflammation

Indexed keywords

COMPLEMENT COMPONENT C3A; FIBRINOGEN; HAPTOGLOBIN; HEMOGLOBIN; HEPARAN SULFATE; HYALURONIC ACID; INDOCYANINE GREEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LIVER ENZYME; MYOGLOBIN; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; IL6 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS EQUIPMENT; CAUSE OF DEATH; CLINICAL PROTOCOL; CYTOKINE RELEASE; DEGRANULATION; GLYCOCALYX; HEART SURGERY; HEMADSORPTION; HEMODYNAMICS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INFLAMMATION; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; LIVER FUNCTION; MAST CELL; MORTALITY; ON-PUMP CARDIAC SURGERY; PILOT STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE ORGAN DYSFUNCTION; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; THERMODILUTION; ADVERSE EFFECTS; AGED; BLOOD; CONTROLLED STUDY; FEMALE; GERMANY; MALE; METHODOLOGY; MULTIPLE ORGAN FAILURE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SORPTION DETOXIFICATION; TIME FACTOR; TREATMENT OUTCOME;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CLINICAL PROTOCOLS; FEMALE; GERMANY; HEMADSORPTION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MULTIPLE ORGAN FAILURE; PILOT PROJECTS; RESEARCH DESIGN; RISK FACTORS; SORPTION DETOXIFICATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84960448301     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1265-9     Document Type: Article

References (36)

1. McGuinness J, Bouchier-Hayes D, Redmond JM. Understanding the inflammatory response to cardiac surgery. Surgeon. 2008;6(3):162.
2. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75(2):S715.
3. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21(2):232.
4. Allan CK, Newburger JW, McGrath E, Elder J, Psoinos C, Laussen PC, et al. The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg. 2010;111(5):1244.
5. Blomquist S, Gustafsson V, Manolopoulos T, Pierre L. Clinical experience with a novel endotoxin adsorption device in patients undergoing cardiac surgery. Perfusion. 2009;24(1):13.
6. Antunes N, Dragosavc D, Petrucci Junior O, Oliveira PP, Kosour C, Blotta MH, et al. The use of ultrafiltration for inflammatory mediators removal during cardiopulmonary bypass in coronary artery bypass graftsurgery. Rev Bras Cir Cardiovasc. 2008;23(2):175.
7. Baksaas ST, Flom-Halvorsen HI, Ovrum E, Videm V, Mollnes TE, Brosstad F, et al. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion. 1999;14(2):107.
8. De Silva RJ, Armstrong J, Bottrill F, Goldsmith K, Colah S, Vuylsteke A. A lipopolysaccharide adsorber in adult cardiopulmonary bypass: a single centre randomised controlled pilot trial. Interact Cardiovasc Thorac Surg. 2010;11(1):86.
9. Schädler D, Porzelius C, Jörres A, Marx G, Meier-Hellmann A, Putensen C, et al. A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients. Crit Care. 2013;17 Suppl 2:P62.
10. Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, De Waele E, van Gorp V, et al. Newly designed CRRT membranes for sepsis and SIRS-a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. Asaio J. 2013;59(2):99.
11. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004;32(3):801.
12. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008;36(5):1573.
13. Taniguchi T. Cytokine adsorbing columns. Contrib Nephrol. 2010;166:134.
14. Quintel M. CytoSorb whole blood cytokine adsorption-results of a controlled randomized trial. Presented at the 32nd International Symposiumon Intensive Care and Emergency Medicine, March 20-23, 2012; Brussels, Belgium. 2012.
15. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
16. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377.
17. CytoSorbents Manufacturers information. http://cytosorb-therapy.com/the-adsorber/. Accessed 14 August 2015.
18. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl. 2012;2:1.
19. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813.
20. Deng MC, Dasch B, Erren M, Mollhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg. 1996;62(1):184.
21. Rimmele T, Venkataraman R, Madden NJ, Elder MM, Wei LM, Pellegrini RV, et al. Comparison of inflammatory response during on-pump and off-pump coronary artery bypass surgery. Int J Artif Organs. 2010;33(3):131.
22. Sander M, von Heymann C, von Dossow V, Spaethe C, Konertz WF, Jain U, et al. Increased interleukin-6 after cardiac surgery predicts infection. Anesth Analg. 2006;102(6):1623.
23. Bruenger F, Kizner L, Weile J, Morshuis M, Gummert JF. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38(2):113.
24. Wiegele M, Krenn CG. Cytosorb in a patient with Legionella pneumonia-associated rhabdomyolysis: a case report. ASAIO J. 2015;61(3):e14.
25. Basu R, Pathak S, Goyal J, Chaudhry R, Goel RB, Barwal A. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: a case study. Indian J Crit Care Med. 2014;18(12):822.
26. Hetz H, Berger R, Recknagel P, Steltzer H. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37(5):422.
27. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61(6):1714.
28. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71(2):745.
29. Haveman JW, Muller Kobold AC, Tervaert JW, van den Berg AP, Tulleken JE, Kallenberg CG, et al. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med. 1999;55(3):132.
30. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125.
31. Franke A, Lante W, Fackeldey V, Becker HP, Thode C, Kuhlmann WD, et al. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Ann Thorac Surg. 2002;74(2):363.
32. Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol. 2008;40(4):257.
33. Annecke T, Chappell D, Chen C, Jacob M, Welsch U, Sommerhoff CP, et al. Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. Br J Anaesth. 2010;104(4):414.
34. Annecke T, Fischer J, Hartmann H, Tschoep J, Rehm M, Conzen P, et al. Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion. Br J Anaesth. 2011;107(5):679.
35. Becker BF, Fischer J, Hartmann H, Chen CC, Sommerhoff CP, Tschoep J, et al. Inosine, not adenosine, initiates endothelial glycocalyx degradation in cardiac ischemia and hypoxia. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1161.
36. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17):1896.